HARTMANN USA and Corstrata Collaborate to Improve Patient Wound Outcomes
Two leading wound industry solutions companies, with a shared passion for improving patient outcomes, are collaborating to improve the way that Home Health and other in-home providers care for patients with chronic wounds.
SAVANNAH, Ga., Oct. 24, 2022 /PRNewswire-PRWeb/ -- HARTMANN USA and Corstrata announce their collaboration to support home health and other in-home providers in caring for wound patients at a time when the incidence of complex chronic wounds is increasing while access to wound care nurse specialists is becoming more challenging. At the core of a successful wound care program is access to both highly effective advanced wound dressings as well as clinical expertise to implement evidence-based treatment protocols and monitor wounds to closure. According to a recent study published by top-50 accounting firm BerryDunn, National Healthcare at Home Best Practices and Future Insights Study, 100% of Home Health Centers of Excellence (those Home Health agencies in the top 10% for quality and patient satisfaction and with a positive financial surplus) have a wound-certified specialist on staff.
This collaboration will increase access to Corstrata's team of virtual board-certified wound nurses (WOC nurses) and HARTMANN's suite of advanced wound care products to improve clinical and financial outcomes for in-home providers that care for patients with chronic wounds.
HARTMANN has been providing advanced wound dressing solutions globally for over 150 years and has evolved with its broad portfolio of high-quality, cost-effective products that provide home health clinicians with a simplified, consistent approach for effectively managing wounds. Corstrata provides virtual wound and ostomy care management nationwide across multiple provider settings, including home health, skilled nursing facilities, hospice, and emerging hospital-at-home solutions companies.
According to Jon Procopio, Managing Director of HARTMANN USA, "Patient care is our priority. HARTMANN strives to enable the progression of the wound towards complete healing that patients deserve and strengthen the confidence that healthcare professionals need to provide wound care. We have a nationwide team of dedicated account and customer care representatives specifically trained for consultation, education, and support in offering clinical and business solutions. Now, with Corstrata, we will enhance access to clinical expertise related to wound care through their team of certified WOC nurses."
"The Corstrata team is excited about this important collaboration with HARTMANN to create access to Corstrata's virtual WOC nurses for customers and the patients they serve. With up to one-third of all home health and hospice patients having a chronic wound, it is critical for clinicians to provide evidence-based care to both prevent and heal wounds," says Joseph Ebberwein, co-founder and Chief Financial Officer of Corstrata. "At this time when agencies are struggling with critical staffing shortages, including WOC nurses, and increasing financial challenges, having a strong wound program is essential. This collaboration between Corstrata and HARTMANN provides a path to success."
According to Katherine Piette, Corstrata's CEO, the decision to collaborate with HARTMANN is an easy one. "Our virtual WOC nurses rely on our provider customers having access to highly effective advanced wound dressings to accelerate wound healing and reduce the overall cost of patient care, " Piette says. "HARTMANN has a unique suite of advanced dressings that are being used by some of the top home health providers in the U.S. with impressive results. We are excited about the opportunity to improve the level of wound care provided for this ever-growing cohort of complex wound patients. Our clients can access clinical support from Corstrata when needed without the cost of hiring their own WOC nurse, a costly and often frustrating proposition. This collaboration will equip providers with turn-key wound solutions that they have been missing in their clinical care delivery at a crucial time in the industry."
About HARTMANN
The HARTMANN GROUP is one of the leading providers of wound treatment and skin integrity solutions around the world. Wound dressings and maintaining healthy skin have been at the heart of HARTMANN from the beginning when we introduced the world's first antiseptic wound dressing over 150 years ago. Overall, HARTMANN looks at rich legacy. Every day, healthcare professionals and patients rely on HARTMANN brands in the segments of Incontinence Management (e.g. MoliCare®), Wound Care (e.g. Zetuvit®) and Infection Management (e. g. Sterillium®). This is expressed in our brand promise of "Helps. Cares. Protects." In 2021, the HARTMANN GROUP reported Group sales of EUR 2.3 billion.
For the latest information on HARTMANN, follow @HARTMANN_GROUP on Twitter.
To learn more about the HARTMANN GROUP, click here.
To learn more about HARTMANN USA, click here.
About Corstrata
Corstrata is a virtual care solution that utilizes technology to provide access to scarce certified wound and ostomy nurses at the patient's bedside in post-acute provider settings, including home health, hospice, skilled nursing facilities, and emerging hospital-at-home providers. Corstrata's team of WOC nurses provides consultations with provider staff at the patient's bedside, either through HIPAA-compliant video or through review of store-and-forward wound images, to improve clinical and financial outcomes for providers.
For the latest information on Corstrata, follow @Corstrata on Twitter.
To learn more about Corstrata, click here.
Media Contact
Reagan Owens, Corstrata, 1 800 566-1307, [email protected]
SOURCE Corstrata
Share this article